Oramed Pharmaceuticals Inc. (ORMP)
Oramed Pharmaceuticals Inc. is a biotech company specializing in the development of oral drug delivery systems for diabetes and other conditions. Its flagship product aims to provide a non-invasive alternative to injectable medications by utilizing innovative oral protein delivery technology. The company focuses on advancing treatments for diabetes and other chronic diseases through its proprietary oral insulin and peptide formulations.
Company News
Oramed Pharmaceuticals announced a joint venture with Hefei Tianhui Biotech to accelerate the development and commercialization of its oral insulin and other oral drug delivery technologies. The new company, OraTech Pharmaceuticals, will receive significant financial backing and leverage HTIT's manufacturing capabilities.
Penny stocks under $5 to watch this week. The post Best Penny Stocks To Buy Today? 4 To Watch Under $5 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
The company's lead pipeline candidate is still being evaluated as a potential treatment for NASH after a major flop in treating type 2 diabetes.